Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 12;17(8):e0272318.
doi: 10.1371/journal.pone.0272318. eCollection 2022.

Hyper-reflective retinal foci as possible in vivo imaging biomarker of microglia activation in von Hippel-Lindau disease

Affiliations

Hyper-reflective retinal foci as possible in vivo imaging biomarker of microglia activation in von Hippel-Lindau disease

Elisabetta Pilotto et al. PLoS One. .

Abstract

Purpose: von Hippel-Lindau (VHL) disease is caused by a mutation of the VHL gene and characterized by the development of retinal hemangioblastomas (RH). Current pathophysiologic mechanisms of RH development and progression are still insufficient to predict RH behavior. VHL gene is involved in the cellular response to hypoxia and in many intracellular signaling pathways expressed both in angiogenesis and inflammation. Optical coherence tomography (OCT) allows to identify hyper-reflective retinal foci (HRF) known as aggregates of activated microglial cells as possible in vivo biomarker of local inflammation. The aim of the present study was to investigate the presence of HRF in patients with genetically confirmed VHL disease.

Methods: In this cross-sectional study, patients with VHL underwent complete ophthalmological examination and OCT with HRA + OCT Spectralis. HRF were manually identified and calculated in inner (IR), outer (OR) and full retina. Age-matched healthy subjects were enrolled as controls.

Results: 113 eyes of 63 VHL patients and 56 eyes of 28 healthy subjects were evaluated. HRF number was significantly higher in VHL than in controls in IR (28.06 ± 7.50 vs 25.25 ± 6.64, p = 0.042). No difference was observed in OR and in full retina (OR: 7.73 ± 2.59 vs 7.95 ± 2.51, p = 0.599; full retina: 35.79 ± 8.77 vs 33.20 ± 7.47, p = 0.093).

Conclusion: The increase of HRF, which mirror retinal microglial activation, characterizes VHL eyes. The role of activated microglia in the retina of VHL eyes needs to be better investigated, mainly considering local VHL disease manifestations.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Hyperreflective retinal foci (HRF) and retinal segmentation.
Hyperreflective retinal foci (HRF) at the OCT linear scan identified in the full retina, from the boundary between nerve fiber layer and ganglion cell layer (RNFL/GCL) to the external limiting membrane (ELM); in Inner Retina (IR), all layers between the boundary between RNFL/GCL and the lower limit of the outer plexiform layer; and in Outer Retina (OR), between the upper limit of the outer nuclear layer and the ELM.
Fig 2
Fig 2. Example of hyperreflective retinal foci (HRF).
Hyperreflective retinal foci (HRF) at the OCT linear scan in one VHL eye (A) and in one healthy control (B). HRF are more numerous in VHL eye than in control, mainly in the Inner Retina.

Similar articles

Cited by

References

    1. Gläsker S, Vergauwen E, Koch CA, Kutikov A, Vortmeyer AO. Von hippel-lindau disease: Current challenges and future prospects. Onco Targets Ther. 2020,13, 5669–90. doi: 10.2147/OTT.S190753 - DOI - PMC - PubMed
    1. Aronow ME, Wiley HE, Gaudric A, Krivosic V, Gorin MB, Shields CL, et al.. Von hippel-lindau disease: Update on pathogenesis and systemic aspects. Retina. 2019,39, 2243–53. doi: 10.1097/IAE.0000000000002555 - DOI - PubMed
    1. Chew MY. Ocular manifestations of von Hippel-Lindau disease: Clinical and genetic investigations. Trans Am Ophthalmol Soc. 2005,103, 495–511. - PMC - PubMed
    1. Wiley HE, Krivosic V, Krivosic V, Gaudric A, Gaudric A, Gorin MB, et al.. Management of retinal hemangioblastoma in von hippel-lindau disease. Retina. 2019,39, 2254–63. doi: 10.1097/IAE.0000000000002572 - DOI - PMC - PubMed
    1. Hajjaj A, van Overdam KA, Gishti O, Ramdas WD, Kiliç E. Efficacy and safety of current treatment options for peripheral retinal haemangioblastomas: a systematic review. Acta Ophthalmol. 2021. doi: 10.1111/aos.14865 - DOI - PubMed

MeSH terms

Substances